SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001013594-06-000161
Filing Date
2006-02-15
Accepted
2006-02-15 13:53:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 FEBRUARY 14, 2006 cell13g-021406.txt SC 13G 12478
  Complete submission text file 0001013594-06-000161.txt   14360
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Subject) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-48459 | Film No.: 06621213
SIC: 2834 Pharmaceutical Preparations

Mailing Address 18 CHURCH STREET, SKANDIA HOUSE HAMILTON D0 HM11
Business Address 18 CHURCH STREET, SKANDIA HOUSE HAMILTON D0 HM11 441-294-3202
Linden Capital L.P. (Filed by) CIK: 0001349339 (see all company filings)

IRS No.: 980430338 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: SC 13G